ZONAGEN INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ZONAGEN INC, 10-Q, EX-11, 2000-11-14
Next: ALAMO GROUP INC, SC 13G, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATIONS FOUND ON
PAGES 5 AND 6 OF THE COMPANY'S 10-Q FOR THE YEAR-TO-DATE, AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          10,397
<SECURITIES>                                    16,971
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                      4,525
<CURRENT-ASSETS>                                32,916
<PP&E>                                           2,150
<DEPRECIATION>                                 (1,536)
<TOTAL-ASSETS>                                  41,185
<CURRENT-LIABILITIES>                            3,311
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            12
<OTHER-SE>                                      37,862
<TOTAL-LIABILITY-AND-EQUITY>                    41,185
<SALES>                                              0
<TOTAL-REVENUES>                                 1,767
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 6,001
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (4,234)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (4,234)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,234)
<EPS-BASIC>                                      (.37)
<EPS-DILUTED>                                    (.37)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission